Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02295956 · ClinicalTrials.gov registry record · Early Phase 1
Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer
A Early Phase 1 study of Pancreatic Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 75
- Enrollment target
- 2
- Study locations
NCT02295956 is a Early Phase 1 study of Pancreatic Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 75 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02295956, a Early Phase 1 study of Pancreatic Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this research study is to learn if it is possible to start a home-based exercise and nutrition program for patients with pancreatic cancer or who may have pancreatic cancer before surgery (pre-operative rehabilitation, also known as prehabilitation).
Conditions Studied
Interventions
- OTHER Exercise
- BEHAVIORAL Questionnaires
- OTHER Booklet
- BEHAVIORAL Phone Calls
- OTHER Nutrition Counseling
Study Locations (2)
Texas
- University of Houston - Houston
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2015-02-02 |
| Est. Completion | 2019-06-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02295956
The ClinicalTrials.gov registry entry for NCT02295956 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (81% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Cancer appearing as the primary indexed condition, and to 5 interventions - of which Exercise is the first listed.
NCT02295956 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02295956 about?
NCT02295956 is a clinical study titled "Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer". The goal of this research study is to learn if it is possible to start a home-based exercise and nutrition program for patients with pancreatic cancer or who may have pancreatic cancer before surgery (pre-operative rehabilitation, also known as prehabilitation).
What is the current status of trial NCT02295956?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 75 participants. The study started on 2015-02-02. Estimated completion is 2019-06-06.
What conditions does trial NCT02295956 study?
This clinical trial studies the following conditions: Pancreatic Cancer.
What interventions are being tested in trial NCT02295956?
The interventions under investigation include: Exercise (OTHER), Questionnaires (BEHAVIORAL), Booklet (OTHER), Phone Calls (BEHAVIORAL), Nutrition Counseling (OTHER).
Who is sponsoring clinical trial NCT02295956?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02295956 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
RECRUITING · Early Phase 1
-
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer
RECRUITING · Early Phase 1
-
Lidocaine Infusion in Pancreatic Cancer
RECRUITING · Early Phase 1
-
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
RECRUITING · Early Phase 1
-
A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma
ACTIVE NOT RECRUITING · Early Phase 1
-
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer
ACTIVE NOT RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.